| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.533 | 27.937 | 31.123 | 42.910 | 55.580 | 67.564 | 50.145 | 59.947 | 70.088 |
| Total Income - EUR | - | 14.533 | 27.943 | 32.990 | 46.782 | 55.591 | 67.577 | 50.160 | 59.973 | 70.116 |
| Total Expenses - EUR | - | 7.522 | 13.033 | 15.164 | 22.970 | 16.850 | 17.343 | 20.468 | 23.280 | 33.731 |
| Gross Profit/Loss - EUR | - | 7.010 | 14.910 | 17.826 | 23.813 | 38.741 | 50.234 | 29.692 | 36.693 | 36.386 |
| Net Profit/Loss - EUR | - | 6.865 | 14.630 | 17.495 | 23.345 | 38.175 | 49.558 | 29.191 | 36.093 | 34.282 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 3 |
Check the financial reports for the company - Dr. Burada Vivi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 115 | 113 | 111 | 109 | 107 | 104 | 0 | 0 | 0 |
| Current Assets | - | 7.801 | 15.464 | 18.815 | 42.332 | 39.796 | 50.748 | 39.473 | 50.405 | 37.303 |
| Inventories | - | 0 | 0 | 317 | 458 | 449 | 439 | 0 | 0 | 729 |
| Receivables | - | 2.002 | 3.117 | 3.456 | 3.841 | 3.679 | 3.794 | 22.787 | 9.273 | 301 |
| Cash | - | 5.798 | 12.347 | 15.043 | 38.033 | 35.667 | 46.515 | 16.686 | 41.133 | 36.274 |
| Shareholders Funds | - | 6.909 | 14.702 | 17.552 | 40.556 | 38.679 | 49.617 | 31.715 | 48.709 | 34.330 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.006 | 875 | 1.374 | 1.884 | 1.224 | 1.235 | 7.758 | 1.697 | 2.973 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Burada Vivi Srl